Seratrodast

Seratrodast is a prescription medicine used to treat people with asthma. It belongs to a class of medicines called leukotriene receptor antagonists (LRAs). It works by blocking certain chemicals in the body called leukotrienes that can cause asthma symptoms. Seratrodast is used to prevent asthma symptoms such as wheezing, coughing, chest tightness, and shortness of breath. It is not used to treat an asthma attack that has already started.

Seratrodast is a medication primarily used to treat mild to moderate asthma. It belongs to a class of drugs called thromboxane A2 (TXA2) receptor antagonists.

Here's a breakdown of what Seratrodast does:

• Mechanism of action: Seratrodast works by blocking the action of thromboxane, a chemical messenger that causes airways to constrict and inflame in people with asthma. This helps to improve breathing and relieve asthma symptoms like coughing, wheezing, and chest tightness.
• Development and Usage: It was the first drug in its class specifically developed for asthma and gained approval in Japan in 1997. As of 2017, it's sold under various brand names like Bronica (Japan), Changnuo (China), and Seradair (India).

Some important things to consider about Seratrodast:

• Form and administration: Information on the form (tablet, capsule, etc.) and method of administration (inhalation, oral, etc.) is not readily available. It's best to consult a doctor for details.
• Side effects: Common side effects include headache, stomach upset, heart palpitations, and drowsiness. In rare cases, it may cause liver problems.
• Pregnancy and lactation: Safety during pregnancy and breastfeeding is not established, so it's best to discuss alternatives with your doctor if you are pregnant or nursing.
• Children: Safety and efficacy in children under 18 years of age are not yet determined.